Cargando…
Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography
Label-free metabolic imaging of non-alcoholic fatty liver disease (NAFLD) mouse liver is demonstrated ex vivo by dynamic optical coherence tomography (OCT). The NAFLD mouse is a methionine choline-deficient (MCD)-diet model, and two mice fed the MCD diet for 1 and 2 weeks are involved in addition to...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Optica Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352293/ https://www.ncbi.nlm.nih.gov/pubmed/35991915 http://dx.doi.org/10.1364/BOE.461433 |
_version_ | 1784762623047237632 |
---|---|
author | Mukherjee, Pradipta Fukuda, Shinichi Lukmanto, Donny Yamashita, Toshiharu Okada, Kosuke Makita, Shuichi Abd El-Sadek, Ibrahim Miyazawa, Arata Zhu, Lida Morishita, Rion Lichtenegger, Antonia Oshika, Tetsuro Yasuno, Yoshiaki |
author_facet | Mukherjee, Pradipta Fukuda, Shinichi Lukmanto, Donny Yamashita, Toshiharu Okada, Kosuke Makita, Shuichi Abd El-Sadek, Ibrahim Miyazawa, Arata Zhu, Lida Morishita, Rion Lichtenegger, Antonia Oshika, Tetsuro Yasuno, Yoshiaki |
author_sort | Mukherjee, Pradipta |
collection | PubMed |
description | Label-free metabolic imaging of non-alcoholic fatty liver disease (NAFLD) mouse liver is demonstrated ex vivo by dynamic optical coherence tomography (OCT). The NAFLD mouse is a methionine choline-deficient (MCD)-diet model, and two mice fed the MCD diet for 1 and 2 weeks are involved in addition to a normal-diet mouse. The dynamic OCT is based on repeating raster scan and logarithmic intensity variance (LIV) analysis that enables volumetric metabolic imaging with a standard-speed (50,000 A-lines/s) OCT system. Metabolic domains associated with lipid droplet accumulation and inflammation are clearly visualized three-dimensionally. Particularly, the normal-diet liver exhibits highly metabolic vessel-like structures of peri-vascular hepatic zones. The 1-week MCD-diet liver shows ring-shaped highly metabolic structures formed with lipid droplets. The 2-week MCD-diet liver exhibits fragmented vessel-like structures associated with inflammation. These results imply that volumetric LIV imaging is useful for visualizing and assessing NAFLD abnormalities. |
format | Online Article Text |
id | pubmed-9352293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Optica Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-93522932022-08-18 Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography Mukherjee, Pradipta Fukuda, Shinichi Lukmanto, Donny Yamashita, Toshiharu Okada, Kosuke Makita, Shuichi Abd El-Sadek, Ibrahim Miyazawa, Arata Zhu, Lida Morishita, Rion Lichtenegger, Antonia Oshika, Tetsuro Yasuno, Yoshiaki Biomed Opt Express Article Label-free metabolic imaging of non-alcoholic fatty liver disease (NAFLD) mouse liver is demonstrated ex vivo by dynamic optical coherence tomography (OCT). The NAFLD mouse is a methionine choline-deficient (MCD)-diet model, and two mice fed the MCD diet for 1 and 2 weeks are involved in addition to a normal-diet mouse. The dynamic OCT is based on repeating raster scan and logarithmic intensity variance (LIV) analysis that enables volumetric metabolic imaging with a standard-speed (50,000 A-lines/s) OCT system. Metabolic domains associated with lipid droplet accumulation and inflammation are clearly visualized three-dimensionally. Particularly, the normal-diet liver exhibits highly metabolic vessel-like structures of peri-vascular hepatic zones. The 1-week MCD-diet liver shows ring-shaped highly metabolic structures formed with lipid droplets. The 2-week MCD-diet liver exhibits fragmented vessel-like structures associated with inflammation. These results imply that volumetric LIV imaging is useful for visualizing and assessing NAFLD abnormalities. Optica Publishing Group 2022-06-30 /pmc/articles/PMC9352293/ /pubmed/35991915 http://dx.doi.org/10.1364/BOE.461433 Text en Published by Optica Publishing Group under the terms of the Creative Commons Attribution 4.0 License. Further distribution of this work must maintain attribution to the author(s) and the published article’s title, journal citation, and DOI. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Mukherjee, Pradipta Fukuda, Shinichi Lukmanto, Donny Yamashita, Toshiharu Okada, Kosuke Makita, Shuichi Abd El-Sadek, Ibrahim Miyazawa, Arata Zhu, Lida Morishita, Rion Lichtenegger, Antonia Oshika, Tetsuro Yasuno, Yoshiaki Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography |
title | Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography |
title_full | Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography |
title_fullStr | Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography |
title_full_unstemmed | Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography |
title_short | Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography |
title_sort | label-free metabolic imaging of non-alcoholic-fatty-liver-disease (nafld) liver by volumetric dynamic optical coherence tomography |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352293/ https://www.ncbi.nlm.nih.gov/pubmed/35991915 http://dx.doi.org/10.1364/BOE.461433 |
work_keys_str_mv | AT mukherjeepradipta labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT fukudashinichi labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT lukmantodonny labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT yamashitatoshiharu labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT okadakosuke labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT makitashuichi labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT abdelsadekibrahim labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT miyazawaarata labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT zhulida labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT morishitarion labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT lichteneggerantonia labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT oshikatetsuro labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography AT yasunoyoshiaki labelfreemetabolicimagingofnonalcoholicfattyliverdiseasenafldliverbyvolumetricdynamicopticalcoherencetomography |